Technical Articles

COPD
全球三大制药巨头围猎IL-33：谁能率先撞线COPD终点？
Global Three Pharmaceutical Giants Hunt for IL-33: Who Will Be the First to Cross the COPD Finish Line?
发布时间 2025-07-31
Sanofi holds a priority review voucher, AstraZeneca bets on a broader population + combination strategy, GSK/Johnson & Johnson uses real-world data and device innovation to overtake on a curve, and where will Astegolimab, this "second-hand bullet", end up.
View details
  • Signaling Pathway
  • IL-33
  • COPD
Total 1
  • 1
Go to
UA
Link：
Products
Application
Cell FactorTarget Proteins
Custom Services
Custom Protein Expression ServicesCustom SPR Services
About Us
PromotionTechnical ArticlesProduct ApplicationFAQsCitationsAbout Us
We Media：
Facebook Linkedin YouTube X Thraeds Pinterest
©2021-2026 all rights reserved UA Biotechnology Co.,Ltd.
Privacy Policy
网站备案号 浙ICP备2022019033号-2 浙公网安备33010202004867号
 Business license (three certificates in one)
Tel：+86-25-56221161
E-mail：order@ua-bio.com
All products sold on this website shall not be used for clinical diagnosis or treatment of humans or animals, and shall only be used for non-medical purposes such as industrial or scientific research.